SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030028
Filing Date
2023-11-02
Accepted
2023-11-02 16:40:37
Documents
82
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20230930_10q.htm   iXBRL 10-Q 1456256
2 EXHIBIT 10.2 SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENT ex_568692.htm EX-10.2 32086
3 EXHIBIT 31.1 ex_568693.htm EX-31.1 8324
4 EXHIBIT 31.2 ex_568694.htm EX-31.2 8349
5 EXHIBIT 32.1 ex_568695.htm EX-32.1 5100
6 EXHIBIT 32.2 ex_568696.htm EX-32.2 5112
  Complete submission text file 0001437749-23-030028.txt   7782471

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20230930.xsd EX-101.SCH 71784
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20230930_cal.xml EX-101.CAL 65761
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20230930_def.xml EX-101.DEF 464669
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20230930_lab.xml EX-101.LAB 427736
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20230930_pre.xml EX-101.PRE 500907
76 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20230930_10q_htm.xml XML 1273161
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 231373109
SIC: 2834 Pharmaceutical Preparations